Nucleic acid-binding properties of low-density lipoproteins: LDL as a natural gene vector

被引:9
|
作者
Guevara, JG
Kang, DC
Moore, JP
机构
[1] Baylor Coll Med, Dept Med, Div Atherosclerosis & Lipoprot Res, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Med, Clin Immunol Sect, Houston, TX 77030 USA
来源
JOURNAL OF PROTEIN CHEMISTRY | 1999年 / 18卷 / 08期
关键词
atherosclerosis; apolipoprotein B; lipid metabolism; gene regulation; protein structure-function; nucleic acids;
D O I
10.1023/A:1020627212272
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The role of apo B-100 as a transcription factor is indicated by the presence of regions in its primary structure that are similar to the DNA-binding domains of the transcription factors ISGF3 gamma, STATs, IRFs, and SREBPs as well as by the presence of 11 RNA-binding KH domains. The Apo B-100 sequence also contains numerous bipartite nuclear localization sequences (NLS). A modified gel shift assay was used to show binding of highly purified preparations of human LDLs to fragmented genomic DNA, plasmid DNA, synthetic oligonucleotides (ISRE, 5'-GGGAAACC-GAAACTG and E/C, E-box motif and CCAAT, adipocyte-specific genes promoter site), and total RNA from human liver. LDL was observed to bind preferentially to plasmid DNA containing the hCMV IE2 promoter region. In experiments using human liver total RNA, RNA for five different genes was recovered from LDL and VLDL bands. Gene transfection experiments using human skin fibroblast cells were used to study the gene transfer capacity of LDL. Cells transfected with a pEGFP-N1 plasmid DNA and LDL expressed functional GFP, as indicated by fluorescence, at approximately 3 hrs after transfection. Our results strongly support an alternative role for apo B-100, in tote or perhaps as functional fragments, in the control of gene expression and as gene transfer vector.
引用
收藏
页码:845 / 857
页数:13
相关论文
共 50 条
  • [31] HETEROGENEITY OF SERUM LOW-DENSITY LIPOPROTEINS (LDL) IN NORMAL HUMAN SUBJECTS
    SHEN, MMS
    KRAUSS, RM
    LINDGREN, FT
    FORTE, T
    CIRCULATION, 1978, 58 (04) : 39 - 39
  • [32] NEW TUMOR LOCALIZERS - ADVANCES IN THE USE OF LOW-DENSITY LIPOPROTEINS (LDL)
    KAHL, SB
    CALLAWAY, JC
    STRAHLENTHERAPIE UND ONKOLOGIE, 1989, 165 (2-3): : 137 - 139
  • [33] INVIVO PROCESSING OF LOW-DENSITY LIPOPROTEINS (LDL) BY A STEROID PRODUCING CELL
    REAVEN, E
    CHEN, YD
    AZHAR, S
    CLINICAL RESEARCH, 1985, 33 (01): : A29 - A29
  • [34] LOW-DENSITY LIPOPROTEINS (LDL) ENHANCE MESANGIAL CELL (MC) APOPTOSIS
    SHARMA, P
    SANKARAN, RT
    AHUJA, TJ
    MATTANA, J
    SINGHAL, PC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 911 - 911
  • [35] REMOVAL OF LOW-DENSITY LIPOPROTEINS (LDL) FROM PLASMA - THE STATE OF THE ART
    KLINKMANN, H
    BEHM, E
    IVANOVICH, P
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1989, 12 (04): : 207 - 210
  • [36] THE OXIDATION OF LOW-DENSITY LIPOPROTEINS (LDL) BY HUMAN MESANGIAL CELLS (HMC)
    FERNANDO, RL
    VARGHESE, Z
    MOORHEAD, JF
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 864 - 864
  • [37] PARAMAGNETICALLY-LABELED LOW-DENSITY LIPOPROTEINS (LDL) - INITIAL CHARACTERIZATION
    KULKARNI, PV
    KATZ, J
    MA, P
    ROMIG, R
    CORBETT, JR
    PARKEY, RW
    BILHEIMER, DW
    PESHOCK, RM
    CIRCULATION, 1987, 76 (04) : 160 - 160
  • [38] SELECTIVE ADSORBENTS FOR LIPOPROTEINS OF LOW-DENSITY (LDL) - INVITRO-STUDIES
    BEHM, E
    LOTH, F
    TOEWE, D
    ERNST, B
    KLINKMANN, H
    ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM, 1988, 43 (02): : 121 - 124
  • [39] Effect of low-density lipoproteins (LDL) on lymphatic vessel intrinsic contractility
    Solari, E.
    Marcozzi, C.
    Negrini, D.
    Moriondo, A.
    ACTA PHYSIOLOGICA, 2019, 227 : 165 - 166
  • [40] The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype
    Dergunov, AD
    Novoselov, AV
    Visvikis, S
    Siest, G
    Yakushkin, VV
    Tsibulsky, V
    BIOLOGICAL CHEMISTRY, 2005, 386 (05) : 441 - 452